Latest News

STAT+: Biden’s policies could spell trouble for biotech — but industry CEOs are backing him anyway





WASHINGTON — From a policy perspective, Joe Biden should be biotech’s worst nightmare. He’s promised to increase the corporate tax rate, dramatically rein in money in politics, and allow Medicare to negotiate over the price of drugs.

But that isn’t stopping major biotech CEOs and investors from personally backing Biden this election cycle.

Continue to STAT+ to read the full story…

Source link







WordPress database error: [Error writing file '/tmp/MYGaYfUQ' (Errcode: 28 - No space left on device)]
SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (439574) AND ( wp_term_relationships.term_taxonomy_id IN (2) ) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY RAND() LIMIT 0, 3

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy